- Filed
- Jun 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Jun 13, 2025 | 52.36M sh |
| Capex | Q3 2025 · Apr 30, 2025 | $0 |
| Capex | Q3 2025 · Apr 30, 2024 | $48K |
| Current Liabilities | Q3 2025 · Apr 30, 2025 | $230.37K |
| Current Liabilities | Q3 2025 · Jul 31, 2024 | $219.01K |
| Total Liabilities | Q3 2025 · Apr 30, 2025 | $265.68K |
| Total Liabilities | Q3 2025 · Jul 31, 2024 | $288.11K |
| Current Assets | Q3 2025 · Apr 30, 2025 | $195.3K |
| Current Assets | Q3 2025 · Jul 31, 2024 | $1.84K |
| Total Assets | Q3 2025 · Apr 30, 2025 | $269.91K |
| Total Assets | Q3 2025 · Jul 31, 2024 | $105.99K |
| Shares Diluted | Q3 2025 · Apr 30, 2024 | 44.91M sh |
| Shares Diluted | Q3 2025 · Apr 30, 2024 | 38.52M sh |
| Operating Cash Flow | Q3 2025 · Apr 30, 2024 | −$94.74K |
| Stockholders Equity | Q3 2025 · Apr 30, 2024 | $7.44M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | −$51.58K |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | −$12.36K |
| Stockholders Equity | Q3 2025 · Jul 31, 2023 | $49.72K |
| Eps Diluted | Q3 2025 · Apr 30, 2024 | −$0.17 |
| Eps Diluted | Q3 2025 · Apr 30, 2024 | −$0.20 |
| Sga Expense | Q3 2025 · Apr 30, 2024 | $7.5M |
| Sga Expense | Q3 2025 · Apr 30, 2024 | $7.56M |
| Net Income | Q3 2025 · Apr 30, 2024 | −$7.51M |
| Net Income | Q3 2025 · Apr 30, 2024 | −$7.61M |
| Net Income | Q3 2025 · Jan 31, 2024 | −$41.65K |
| Net Income | Q3 2025 · Oct 31, 2023 | −$62.99K |
| Operating Income | Q3 2025 · Apr 30, 2024 | −$7.51M |
| Operating Income | Q3 2025 · Apr 30, 2024 | −$7.62M |
| Gross Profit | Q3 2025 · Apr 30, 2024 | $0 |
| Gross Profit | Q3 2025 · Apr 30, 2024 | $0 |
| Cost Of Revenue | Q3 2025 · Apr 30, 2024 | $0 |
| Cost Of Revenue restated | Q3 2025 · Apr 30, 2024 | $0 |
| Revenue | Q3 2025 · Apr 30, 2024 | $0 |
| Revenue | Q3 2025 · Apr 30, 2024 | $0 |